General Practice Doctors in Atlantis, FL Accepting Medicare

2 General Practice doctors found. Showing 1 - 2

Dr. M Rahat Faderani, D.O., M.P.H. General Practice Medicare: Not Enrolled in Medicare Practice Location: 5913 S Congress Ave, Atlantis, FL 33462 Phone: 561-965-4300    Fax: 561-965-4399

Farrell Sheehan, MD General Practice Medicare: Medicare Enrolled Practice Location: 180 Jfk Dr Ste 210, Atlantis, FL 33462 Phone: 561-548-1450

News Archive

Study shows importance of disclosing physician conflicts of interest in MS ISCTs to potential participants

If you're one of the nearly half a million Americans living with multiple sclerosis (MS) - a slowly disabling disease of the central nervous system - you are likely dependent on disease-modifying drugs to prevent symptoms such as vision problems, balance issues and weakness. Often, these treatments have been developed through pharmaceutical industry-sponsored clinical trials (ISCT) in collaboration with academic or private practice physicians who care for MS patients.

Meningitis outbreak spreads; Mass. revokes Compounding Center's license

The Massachusetts Board of Pharmacy has permanently revoked the license of the New England Compounding Center, the facility implicated in a nationwide outbreak of fungal meningitis, Gov. Deval Patrick announced Tuesday. ... State Director of Healthcare Safety Madeleine Biondolillo said ... investigators witnessed "black particulate matter" in some vials of medicine returned amid the nationwide recall of NECC's products.

International community must help women fight HIV/AIDS in Swaziland

Women living with HIV in Swaziland "fight a tireless tripartite battle against HIV, the stigma it places on them, and their inferior status in Africa's last absolute monarchy," freelance journalist Gary Nunn writes in the Guardian's "Poverty Matters Blog."

Bacterin International closes private placement

Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.

Read more Medical News

› Verified 3 days ago